{"name":"Penumbra Inc.","slug":"penumbra-inc","ticker":"","exchange":"","domain":"","description":"The umbra, penumbra and antumbra are three distinct parts of a shadow, created by any light source after impinging on an opaque object of lesser size. In cases of equal or smaller impinging objects, only an umbra and penumbra are generated. Assuming no diffraction, for a collimated beam of light, only the umbra is cast.","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":1403665000,"revenueGrowth":17.5,"grossMargin":0,"rdSpend":36165000,"netIncome":177687000,"cash":1826519000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitAJBVV95cUxOa3JVOVVlVDhQZUJLOU92czBJZnpOODFLaXhQMjVJTDlLWmc2UHIwaTNkcFNPcHYwVWNOQWJwbGo0aldzSDd2NzVRVzRueFNiM0ZkTEp1MWpQdkt3a3BxbjQwMkZUR2VDamlwWUN0UFNrWmRLMDNkaDFzc3hlVkR3ZV90Uml6RlRSUnEyNkg3QlBVclVCOE9wMW81eC11cTd4SGRyYXVWRUhtM3FrYTlUZGY4b1poclZCOXhta2VwWUFSdm53a1kza0RqaE5ydU0zS3NEdk05WU1VZHVsdUVZLXRRZ1k1cnlPMzdwak9hbDZGdXMtSWhTLS1mSHd0SU01VUhMTHBHcWFEQ1dmQ0piaUdxcDlmWmJ3WEdvQ2U0VnpnZ016TTlmN2psZkJISzUtdmlWcA?oc=5","date":"2026-03-25","type":"pipeline","source":"Business Wire","summary":"Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Terns Pharmaceuticals, Inc. - TERN - Business Wire","headline":"Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQLXl2Q1p2cGlfd1YtQUlva2hlZ1J1eWs4V1JkLXVoSG95clZHdGJDOFBzU00xRzhHLXpuS2R4Z2RLci10UHhrbXNXcmRmdzA4WFFHWE95QUFqeTBHTGJVMXhDUVFjNVNwZzM3Qk8zUkJoaVBOcnNCaENBOWRfTm1vM0o3c0tmQ2QxRWx2OXBfTUlzNmpaMTg0bkpaYWU0Mm9tY19WQk5wVFlVMDFTZ0s2WWxxT1RqRG1Ib191T3V0c25zN1QteVhJ?oc=5","date":"2026-02-25","type":"earnings","source":"PR Newswire","summary":"Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results - PR Newswire","headline":"Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results","sentiment":"neutral"},{"date":"2026-02-25","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-02-25","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNSzdlVkpFeGptTlVsTGJ0TGRUeDdKVC03WjE2TmFZc3dyZGhtb1lkRFpEYTBpbXJUREV4YW4zV2RqUE9EYUdvU3lVYVpIa1p3V2VHcW51eXV6Mnk0dW9RWi1ORmhKVlU1WkRzYW5XUDA0eGpHWG1zLTlrQjZTUk5wTzdDQWdlRHoyU1FyVlJ3VW8xNjVZ?oc=5","date":"2026-02-24","type":"deal","source":"The Business Journals","summary":"Boston Scientific adds Starbucks CFO, Takeda CEO to board amid $14.5B buying spree - The Business Journals","headline":"Boston Scientific adds Starbucks CFO, Takeda CEO to board amid $14.5B buying spree","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5BMlZZcThucUp0ZkZkN0hfdTRvbklIVm5abzVYd3ZLbnJldldvYTlGQncxd2NoZFJmOVJiVC1zMDU3V3ZiM3pYdTV4TTFNbEpHa1h0SWNaOEphN1RqbzdhWmsxbmVUX0NlSEFqdDJxNWNYSm5YbU1MSGVucw?oc=5","date":"2026-01-19","type":"deal","source":"dicardiology.com","summary":"Boston Scientific to Acquire Penumbra - dicardiology.com","headline":"Boston Scientific to Acquire Penumbra","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNVVlQMElFcnlldlQ4X3R3Mko5Sy16V3ZJanZUcVpoZzgtLTczbFhpT1B4Z251bkJtM1pvMVY2N0I0bXlObHNDRjJOejQyM3FhQzZ1TVhEby1rSENPSzZCQ0JMRUhWN2MzS2xULXZYUlIxU1BqOXNIZDQ5UkZFbk8tUXkwOUN1V0xRaHMtcEhXMTVXN0lxVnhhRXhFSG4wYnZpZURZQWwzQWhOWU1qbUoxazN2VXpmY2xOSjRjWlF2dEE3X25w?oc=5","date":"2026-01-15","type":"deal","source":"Reuters","summary":"Boston Scientific beefs up heart device portfolio with $14.5 billion Penumbra deal - Reuters","headline":"Boston Scientific beefs up heart device portfolio with $14.5 billion Penumbra deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQY2h6OGpub0hCM2d0Q3FFeHJ3cjE5LWFGVzdIazdDUmNxVF8tTDJ3bWN5N0QyLVRIMTZrdlNwX25DaXkxYi1pcm84OUkwem93V244bVd4Wm9KemMteGNUa0ZkRU9mLXdfYV9pTE1iQlJ3ZVU5SUR0VHN6Y2VFT2JNSXQ4eE40Z0phZk9yV2Y5TllWN2ZIMGh6aEl3aS1qdlpkaFpUaFFxS3LSAa4BQVVfeXFMUG9kbTNZOVVBcWViTS1PUEZIUTZXWFRVNXdjZ0NBNlNCWW1ld3NaVWNtVllxMmlKVlpMalBoTUdqczFhWFdlNTd3VmJCTk9EcmVqSlIwRjV1LUtTcHRXMnhRZHhzcWdkTVVBbkxCd3NIVHVqVTBHV0xUQXdOY3R1d20zWnJEVEJqZG00N21VTXVjNG9FMGJHUl8xb3VZNjJJWTNnbEt6b29ITmJSM3Z3?oc=5","date":"2026-01-15","type":"deal","source":"CNBC","summary":"Boston Scientific beefs up heart device portfolio with $14.5 billion Penumbra deal - CNBC","headline":"Boston Scientific beefs up heart device portfolio with $14.5 billion Penumbra deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQemI0NnB4YzZNMXNpeEc0UTN6eXF1blJneFB0OHBBZnhBbFJrU2tQUENBbGpNRzJKZzZSd0FjRXNMUXpiWUlEZ08yOFpocmlBTGxaMFVfTEo0dlBBd2NhdkFFTDhuNG16RUg3c3NtMHF6WTNROTEyV0xwWmhZTTZjRjlDeFhPRnJneDhuMG1jZUotS1F3X21WZ2ZDVnRrZXV5SF9NSEJqVlNMQmNsdjN5ZXlOdHpuQ2ZC?oc=5","date":"2026-01-15","type":"deal","source":"PR Newswire","summary":"Boston Scientific announces agreement to acquire Penumbra, Inc. - PR Newswire","headline":"Boston Scientific announces agreement to acquire Penumbra, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxQMU1XbXRJZnFLaGxpcjhhMjJUVTljNWpyOUxSWXNlbVZuT19vamY0OTRiaWUxdEN0Y3dGeWxYblJYRzFlQ1pXN1M2d0R2cjRyVXlXSTIyYXhWb1ViNE9XUG1BekhpYldaRm9uMWUzVnh0LUhrYXk4QVJPeHRtV1NHQVh3QlNtdDVVWkQ5QThfdUlqVnBWZXJ0cEZqb2x5b3NFX19NNG1WbDEtQW9HVzRLbmIxT09wZjRNWndfblJTOUtfdWpON3VRSnBxWDhLTlN6eHVDbDBVa3ZYamprRVhNc1VrUVBJZw?oc=5","date":"2026-01-15","type":"earnings","source":"PR Newswire","summary":"Penumbra, Inc. Provides Preliminary Update on Fourth Quarter and Full Year 2025 Financial Results - PR Newswire","headline":"Penumbra, Inc. Provides Preliminary Update on Fourth Quarter and Full Year 2025 Financial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxOR3ZtWlFSZzJScEFLZmhPS19YRjBQOGdNQTRjaUZ1cklvb05ta3NVZHdnTUJyM0lTcFRHMHRFblliZWw3Uzl6SnJtS0hhaU83VW4tU1pydkxZOVA5V3hmcEF5anhOa1NjZUctVU8tMWZZNUNsa3M0c2RzNDI5VGhwOHFfanRoeU5jX21TcTBGVkdCRThxXzhpeTdBbmRYQ0VTVk90ZzluZW5kY2ZWSHlmWWc1QTFfZ1Z4eFVwWFg3R2NISTlXQmluQnln?oc=5","date":"2025-12-29","type":"pipeline","source":"PR Newswire","summary":"Penumbra, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference - PR Newswire","headline":"Penumbra, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPMzRSZDhQa1Y5RllQdEg2SVdLdWN2ODYxTUI1aVpEUlhOSU9LR1FmWnQzUk1NeEc1M1MxeExTZ1dCTmxrYkdiWHFZOFBRejVtd2RTcHA3VjRralJlbnNNTzFtWERIMTNkMmlFUXhTSV9BdFYySDd3a09WemZtRklTcFdiQkRjYlBvZjdqSy1WUER4SmV5ck02V1VBaGJDNmxiemo0VFI1UksyLTZFdUVkWUFTbw?oc=5","date":"2025-11-05","type":"earnings","source":"PR Newswire","summary":"Penumbra, Inc. Reports Third Quarter 2025 Financial Results - PR Newswire","headline":"Penumbra, Inc. Reports Third Quarter 2025 Financial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOSDNTdEdCcEMxbjZYMlRpZWRXUF9uSXY4a2hRb3hPazZGVGRTaVAtbHd4cjhZUG5NOXNKdGUxQmt6QjRjNmhGT3ZfcVV4MmVHX1VwbDRmZ2tyVmF3UHQ2TEowWm1OWUhkaG9ZdEFwT0RLRVl2dFVta1U5d2JJazF5ZFRHU0g0S25VQ0ZRZWRUZ2l2Q2pvWUtybWVOZnItRkJNUGk0RVNibmVlblNVUjhLYg?oc=5","date":"2025-08-27","type":"pipeline","source":"PR Newswire","summary":"Penumbra, Inc. Names Shruthi Narayan as Company President - PR Newswire","headline":"Penumbra, Inc. Names Shruthi Narayan as Company President","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNei1UQ3RNcUZiWmpEMDJRazFCam5RMi1nNlJiVDQ0Qi1NOE1YOVM3OFpQeTM3NlE3d0R4UEJSVlNiZllBNzc5UHNBcEotaV8yTzRJZzVEb0xfSTJIOVFnbEhnSmd4QUxkeXFKcVRHbHRGTlRRWWd1aW1rT01xTkhRVG5NalZKN1RVSUxobWJSWTgxdElTbmNzbFFXSVEzTmhhMGRBdXJ5LUwwTndHX1owdXRCaW0?oc=5","date":"2025-07-29","type":"earnings","source":"PR Newswire","summary":"Penumbra, Inc. Reports Second Quarter 2025 Financial Results - PR Newswire","headline":"Penumbra, Inc. Reports Second Quarter 2025 Financial Results","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":1403665000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":1403665000,"period":"2025-12-31"},{"value":1194615000,"period":"2024-12-31"},{"value":1194615000,"period":"2024-12-31"},{"value":1058522000,"period":"2023-12-31"},{"value":1058522000,"period":"2023-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":36165000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":177687000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":1826519000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}